Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease

American Journal of Medicine

Volumn 100, Issue 1 A, 1996, Pages S11-S18

  Colice, G L ^a  

^a VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IPRATROPIUM BROMIDE; SALBUTAMOL; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ANTICHOLINERGIC EFFECT; BRONCHITIS; CHOLECYSTITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COUGHING; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEBULIZATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; STOMACH HEMORRHAGE; AMBULATORY CARE; ARTICLE; COMPARATIVE STUDY; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; AGED; ALBUTEROL; AMBULATORY CARE; BRONCHODILATOR AGENTS; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IPRATROPIUM; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 0030605291     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(96)80037-4     Document Type: Conference Paper

References (29)

1. Gross N.J. Skorodin M.S. Anticholinergic, antimuscarinic bronchodilators Am Rev Respir Dis 129 1984 856 870
2. Gross N.J. Ipratropium bromide N EngtJ Med 319 1988 486 494
3. Jenkins C.R. Chow C.M. Fisher B.L. Marlin G.E. Comparison of ipratropium bromide and salbutamol by aerosolized solution Aust NZ J Med 11 1981 513 516
4. Gross N.J. Skorodin M.S. Role of the parasympathetic system in airway obstruction due to emphysema N Engl J Med 311 1984 421 425
5. Easton P.A. Jadue C. Dhingra S. Anthonisen N.R. A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide) given by aerosol alone or in sequence N Engl J Med 315 1986 735 739
6. Karpel J.P. Bronchodilator, responses to anticholinergic and beta-adrenergic agents in acute and stable COPD Chest 99 1991 871 876
7. Nisar M. Earis J.E. Pearson M.G. Calverley P.M.A. Acute bronchodilator trials in chronic obstructive pulmonary disease Am Rev Respir Dis 146 1992 555 559
8. Tashkin D.P. Ashutosh K. Bleecker E.R. Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease Am J Med 81 suppl 5A 1986 81S 89S
9. Braun S.R. McKenzie W.N. Copeland C. Knight L. Ellersieck M. A comparison of the effect of ipratropium bromide and albuterol in the treatment of chronic obstructive airway disease Arch Intern Med 149 1989 544 547
10. Braun S.R. Levy S.F. Grossman J. Comparison of Ipratropium bromide and albuterol in chronic obstructive pulmonary disease: a three-center study Am J Med 91 suppl 4A 1991 28S 32S
11. Teale C. Morrison J.F.J. Jones P.C. Muers M.E. Reversibility tests in chronic obstructive airways disease: their predictive value with reference to benefit from domiciliary nebuliser therapy Resp Med 85 1991 281 284
12. Morrison J.F.J. Jones P.C. Muers M.E. Assessing physiological benefit from domiciliary nebulized bronchodilators in severe airflow limitation Eur Respir J 5 1992 424 429
13. O'Driscoll B.R. Kay E.A. Taylor R.J. Weatherby H. Chetty M.C.P. Bernstein A. A long-term prospective assessment of home nebulizer treatment Resp Med 86 1992 317 325
14. Morris J.F. Koski A. Temple W.P. Claremont A. Thomas D.R. Fifteen-year interval spirometric evaluation of the Oregon predictive equations Chest 93 1988 123 127
15. Guyatt G.H. Townsend M. Pugsley S.O. Keller J.L. Short H.D. Taylor D.W. Newhouse M.T. Bronchodilators in chronic air-flow limitation Am Rev Respir Dis 135 1987 1069 1074
16. Guyatt G.H. Berman L.B. Townsend M. Pugsley S.O. Chambers L.W. A measure of quality of life for clinical trials in chronic lung disease Thorax 42 1987 773 778
17. Juniper E.F. Guyatt G.H. Ferrie P.J. Griffith L.E. Measuring quality of life in asthma Am Rev Respir Dis 147 1993 832 838
18. Guyatt G.H. Feeny D.H. Patrick D.L. Measuring health-related quality of life Ann Intern Med 118 1993 622 629
19. Repsher L.H. Anderson J.A. Bush R.K. Assessment of tachyphylaxis following prolonged therapy of asthma with inhaled albuterol aerosol Chest 85 1984 34 38
20. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma N Engl J Med 327 1992 1198 1203
21. Guyatt G.H. Townsend M. Nogradi S. Pugsley S.O. Keller J.L. Newhouse M.T. Acute response to bronchodilator: an imperfect guide for bronchodilator therapy in chronic airflow limitation Arch Intern Med 148 1988 1949 1952
22. Mahler D.A. Rosiello R.A. Harver A. Lentine T. McGovern J.F. Daubenspeck J.A. Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airways disease Am Rev Respir Dis 135 1987 1229 1233
23. Sweer L. Zwillich C.W. Dyspnea in the patient with chronic obstructive pulmonary disease Clin Chest Med 11 1990 417 445
24. Turner J.R. Corkery K.J. Eckman D. Gelb A.M. Lipavsky A. Sheppard D. Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction Chest 93 1988 476 481
25. Tenholder M.F. Bryson M.J. Whitlock W.L. A model for conversion from small volume nebulizer to metered-dose inhaler aerosol therapy Chest 101 1992 634 637
26. Newman S.P. Woodman G. Clarke S.W. Sackner M.A. Effect of InspirEase on the deposition of metered-dose aerosols in the human respiratory tract Chest 89 1986 551 556
27. Sears M.R. Taylor D.R. Print C.G. Lake D.C. Regular inhaled beta-agonist treatment in bronchial asthma Lancet 336 1990 1391 1396
28. van Schayck C.P. Rutten-van Molken M.P.M.H. van Doorslaer E.K.A. Folgering H. van Weel C. Two year bronchodilator treatment in patients with mild airflow obstruction Chest 102 1992 1384 1391
29. van Schayck C.P. Dompeling e. van Herwaarden C.L.A. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomized controlled study Brit Med J 303 1991 1426 1431